Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Transcription profiling of CD4⁺ T cells in rhesus macaques that infected with simian-human immunodeficiency virus and re-challenged with SIVmac251.

Chung HK, Pise-Masison CA, Muthiah A, Radonovich MF, Lee EM, Lee JK, Pal R.

J Med Primatol. 2015 Oct;44(5):263-74. doi: 10.1111/jmp.12185. Epub 2015 Aug 31.

PMID:
26332118
2.

The transcription profile of Tax-3 is more similar to Tax-1 than Tax-2: insights into HTLV-3 potential leukemogenic properties.

Chevalier SA, Durand S, Dasgupta A, Radonovich M, Cimarelli A, Brady JN, Mahieux R, Pise-Masison CA.

PLoS One. 2012;7(7):e41003. doi: 10.1371/journal.pone.0041003. Epub 2012 Jul 20.

3.

Gene expression profiling of ATL patients: compilation of disease-related genes and evidence for TCF4 involvement in BIRC5 gene expression and cell viability.

Pise-Masison CA, Radonovich M, Dohoney K, Morris JC, O'Mahony D, Lee MJ, Trepel J, Waldmann TA, Janik JE, Brady JN.

Blood. 2009 Apr 23;113(17):4016-26. doi: 10.1182/blood-2008-08-175901. Epub 2009 Jan 8.

4.

Cellular gene expression profiles in rhesus macaques challenged mucosally with a pathogenic R5 tropic simian human immunodeficiency virus isolate.

Chung HK, Pise-Masison CA, Radonovich MF, Brady J, Lee JK, Cheon SY, Markham P, Cristillo A, Pal R.

Viral Immunol. 2008 Dec;21(4):411-23. doi: 10.1089/vim.2008.0076.

5.

Exenatide blocks JAK1-STAT1 in pancreatic beta cells.

Couto FM, Minn AH, Pise-Masison CA, Radonovich M, Brady JN, Hanson M, Fernandez LA, Wang P, Kendziorski C, Shalev A.

Metabolism. 2007 Jul;56(7):915-8.

PMID:
17570252
6.

Genomic identification of potential risk factors during acetaminophen-induced liver disease in susceptible and resistant strains of mice.

Welch KD, Reilly TP, Bourdi M, Hays T, Pise-Masison CA, Radonovich MF, Brady JN, Dix DJ, Pohl LR.

Chem Res Toxicol. 2006 Feb;19(2):223-33.

PMID:
16485898
7.

Expression profiling of mucinous tumors of the ovary identifies genes of clinicopathologic importance.

Wamunyokoli FW, Bonome T, Lee JY, Feltmate CM, Welch WR, Radonovich M, Pise-Masison C, Brady J, Hao K, Berkowitz RS, Mok S, Birrer MJ.

Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):690-700.

8.

Characterization and isolation of stem cell-enriched human hair follicle bulge cells.

Ohyama M, Terunuma A, Tock CL, Radonovich MF, Pise-Masison CA, Hopping SB, Brady JN, Udey MC, Vogel JC.

J Clin Invest. 2006 Jan;116(1):249-60.

9.

Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.

Bonome T, Lee JY, Park DC, Radonovich M, Pise-Masison C, Brady J, Gardner GJ, Hao K, Wong WH, Barrett JC, Lu KH, Sood AK, Gershenson DM, Mok SC, Birrer MJ.

Cancer Res. 2005 Nov 15;65(22):10602-12.

10.

Gene expression profiling in INS-1 cells overexpressing thioredoxin-interacting protein.

Minn AH, Pise-Masison CA, Radonovich M, Brady JN, Wang P, Kendziorski C, Shalev A.

Biochem Biophys Res Commun. 2005 Oct 28;336(3):770-8.

PMID:
16143294
11.

Activated AKT regulates NF-kappaB activation, p53 inhibition and cell survival in HTLV-1-transformed cells.

Jeong SJ, Pise-Masison CA, Radonovich MF, Park HU, Brady JN.

Oncogene. 2005 Oct 6;24(44):6719-28.

PMID:
16007163
12.

Global analysis of IL-2 target genes: identification of chromosomal clusters of expressed genes.

Kovanen PE, Young L, Al-Shami A, Rovella V, Pise-Masison CA, Radonovich MF, Powell J, Fu J, Brady JN, Munson PJ, Leonard WJ.

Int Immunol. 2005 Aug;17(8):1009-21. Epub 2005 Jun 24.

PMID:
15980098
13.

Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function.

Zeng R, Spolski R, Finkelstein SE, Oh S, Kovanen PE, Hinrichs CS, Pise-Masison CA, Radonovich MF, Brady JN, Restifo NP, Berzofsky JA, Leonard WJ.

J Exp Med. 2005 Jan 3;201(1):139-48.

14.

A novel NF-kappaB pathway involving IKKbeta and p65/RelA Ser-536 phosphorylation results in p53 Inhibition in the absence of NF-kappaB transcriptional activity.

Jeong SJ, Pise-Masison CA, Radonovich MF, Park HU, Brady JN.

J Biol Chem. 2005 Mar 18;280(11):10326-32. Epub 2004 Dec 20.

15.

Whole genome expression profiling of advance stage papillary serous ovarian cancer reveals activated pathways.

Donninger H, Bonome T, Radonovich M, Pise-Masison CA, Brady J, Shih JH, Barrett JC, Birrer MJ.

Oncogene. 2004 Oct 21;23(49):8065-77.

PMID:
15361855
16.

HTLV-I Tax induces a novel interaction between p65/RelA and p53 that results in inhibition of p53 transcriptional activity.

Jeong SJ, Radonovich M, Brady JN, Pise-Masison CA.

Blood. 2004 Sep 1;104(5):1490-7. Epub 2004 May 20. Erratum in: Blood. 2007 Jan 15;109(2):411.

PMID:
15155458
17.

Stat5 synergizes with T cell receptor/antigen stimulation in the development of lymphoblastic lymphoma.

Kelly JA, Spolski R, Kovanen PE, Suzuki T, Bollenbacher J, Pise-Masison CA, Radonovich MF, Lee S, Jenkins NA, Copeland NG, Morse HC 3rd, Leonard WJ.

J Exp Med. 2003 Jul 7;198(1):79-89. Epub 2003 Jun 30.

18.

P53 facilitates degradation of human T-cell leukaemia virus type I Tax-binding protein through a proteasome-dependent pathway.

Chowdhury IH, Radonovich M, Mahieux R, Pise-Masison C, Muralidhar S, Brady JN.

J Gen Virol. 2003 Apr;84(Pt 4):897-906.

PMID:
12655090
19.

Protective role of Kupffer cells in acetaminophen-induced hepatic injury in mice.

Ju C, Reilly TP, Bourdi M, Radonovich MF, Brady JN, George JW, Pohl LR.

Chem Res Toxicol. 2002 Dec;15(12):1504-13.

PMID:
12482232
20.

Oligonucleotide microarray analysis of intact human pancreatic islets: identification of glucose-responsive genes and a highly regulated TGFbeta signaling pathway.

Shalev A, Pise-Masison CA, Radonovich M, Hoffmann SC, Hirshberg B, Brady JN, Harlan DM.

Endocrinology. 2002 Sep;143(9):3695-8.

PMID:
12193586
21.

Transcription profile of cells infected with human T-cell leukemia virus type I compared with activated lymphocytes.

Pise-Masison CA, Radonovich M, Mahieux R, Chatterjee P, Whiteford C, Duvall J, Guillerm C, Gessain A, Brady JN.

Cancer Res. 2002 Jun 15;62(12):3562-71.

22.

Acetylation of nucleosomal histones by p300 facilitates transcription from tax-responsive human T-cell leukemia virus type 1 chromatin template.

Lu H, Pise-Masison CA, Fletcher TM, Schiltz RL, Nagaich AK, Radonovich M, Hager G, Cole PA, Brady JN.

Mol Cell Biol. 2002 Jul;22(13):4450-62.

23.

A protective role for cyclooxygenase-2 in drug-induced liver injury in mice.

Reilly TP, Brady JN, Marchick MR, Bourdi M, George JW, Radonovich MF, Pise-Masison CA, Pohl LR.

Chem Res Toxicol. 2001 Dec;14(12):1620-8.

PMID:
11743745
24.

Saccharomyces cerevisiae protein Pci8p and human protein eIF3e/Int-6 interact with the eIF3 core complex by binding to cognate eIF3b subunits.

Shalev A, Valásek L, Pise-Masison CA, Radonovich M, Phan L, Clayton J, He H, Brady JN, Hinnebusch AG, Asano K.

J Biol Chem. 2001 Sep 14;276(37):34948-57. Epub 2001 Jul 16.

25.

9-Nitrocamptothecin inhibits HIV-1 replication in human peripheral blood lymphocytes: a potential alternative for HIV-infection/AIDS therapy.

Hung CL, Doniger J, Palini A, Snyder SW, Radonovich MF, Brady JN, Pantazis P, Sadaie MR.

J Med Virol. 2001 Jul;64(3):238-44.

PMID:
11424110
26.

Expression profiling of acetaminophen liver toxicity in mice using microarray technology.

Reilly TP, Bourdi M, Brady JN, Pise-Masison CA, Radonovich MF, George JW, Pohl LR.

Biochem Biophys Res Commun. 2001 Mar 23;282(1):321-8. Erratum in: Biochem Biophys Res Commun 2001 May 4;283(2):536.

PMID:
11264010
27.

Insights into the molecular mechanism of p53 inhibition by HTLV type 1 Tax.

Pise-Masison CA, Mahieux R, Radonovich M, Jiang H, Duvall J, Guillerm C, Brady JN.

AIDS Res Hum Retroviruses. 2000 Nov 1;16(16):1669-75. Review.

PMID:
11080808
28.

Human T-lymphotropic virus type I Tax protein utilizes distinct pathways for p53 inhibition that are cell type-dependent.

Pise-Masison CA, Mahieux R, Radonovich M, Jiang H, Brady JN.

J Biol Chem. 2001 Jan 5;276(1):200-5.

29.
30.

Inactivation of p53 by human T-cell lymphotropic virus type 1 Tax requires activation of the NF-kappaB pathway and is dependent on p53 phosphorylation.

Pise-Masison CA, Mahieux R, Jiang H, Ashcroft M, Radonovich M, Duvall J, Guillerm C, Brady JN.

Mol Cell Biol. 2000 May;20(10):3377-86.

31.

Phosphorylation of p53 serine 15 increases interaction with CBP.

Lambert PF, Kashanchi F, Radonovich MF, Shiekhattar R, Brady JN.

J Biol Chem. 1998 Dec 4;273(49):33048-53.

32.

Phosphorylation of p53: a novel pathway for p53 inactivation in human T-cell lymphotropic virus type 1-transformed cells.

Pise-Masison CA, Radonovich M, Sakaguchi K, Appella E, Brady JN.

J Virol. 1998 Aug;72(8):6348-55.

33.

Inhibition of p53 transactivation function by the human T-cell lymphotropic virus type 1 Tax protein.

Pise-Masison CA, Choi KS, Radonovich M, Dittmer J, Kim SJ, Brady JN.

J Virol. 1998 Feb;72(2):1165-70.

34.

Interaction of the human T-cell lymphotropic virus type 1 tax transactivator with transcription factor IIA.

Clemens KE, Piras G, Radonovich MF, Choi KS, Duvall JF, DeJong J, Roeder R, Brady JN.

Mol Cell Biol. 1996 Sep;16(9):4656-64.

35.

Human T-cell leukemia virus type I Tax protein transactivates RNA polymerase III promoter in vitro and in vivo.

Piras G, Dittmer J, Radonovich MF, Brady JN.

J Biol Chem. 1996 Aug 23;271(34):20501-6.

36.

Interaction of human immunodeficiency virus type 1 Tat with a unique site of TFIID inhibits negative cofactor Dr1 and stabilizes the TFIID-TFIIA complex.

Kashanchi F, Khleif SN, Duvall JF, Sadaie MR, Radonovich MF, Cho M, Martin MA, Chen SY, Weinmann R, Brady JN.

J Virol. 1996 Aug;70(8):5503-10.

37.

Transactivation of the human T-cell lymphotropic virus type 1 Tax1-responsive 21-base-pair repeats requires Holo-TFIID and TFIIA.

Duvall JF, Kashanchi F, Cvekl A, Radonovich MF, Piras G, Brady JN.

J Virol. 1995 Aug;69(8):5077-86.

38.

Transcription of the human T-cell lymphotropic virus type I promoter by an alpha-amanitin-resistant polymerase.

Piras G, Kashanchi F, Radonovich MF, Duvall JF, Brady JN.

J Virol. 1994 Oct;68(10):6170-9.

39.

Direct interaction of human TFIID with the HIV-1 transactivator tat.

Kashanchi F, Piras G, Radonovich MF, Duvall JF, Fattaey A, Chiang CM, Roeder RG, Brady JN.

Nature. 1994 Jan 20;367(6460):295-9.

PMID:
8121496
40.

Sequences downstream of the RNA initiation site regulate human T-cell lymphotropic virus type I basal gene expression.

Kashanchi F, Duvall JF, Lindholm PF, Radonovich MF, Brady JN.

J Virol. 1993 May;67(5):2894-902.

41.
42.

Purification of PO-B, a protein that has increased affinity for the pro-opiomelanocortin gene promoter after dephosphorylation.

Wellstein A, Dobrenski AF, Radonovich MN, Brady JF, Riegel AT.

J Biol Chem. 1991 Jul 5;266(19):12234-41.

43.
45.
46.

Simian virus 40 guanine-cytosine-rich sequences function as independent transcriptional control elements in vitro.

Mishoe H, Brady JN, Radonovich M, Salzman NP.

Mol Cell Biol. 1984 Dec;4(12):2911-20.

47.

Stimulation of simian virus 40 late gene expression by simian virus 40 tumor antigen.

Brady J, Bolen JB, Radonovich M, Salzman N, Khoury G.

Proc Natl Acad Sci U S A. 1984 Apr;81(7):2040-4.

48.

Simian virus 40 major late promoter: an upstream DNA sequence required for efficient in vitro transcription.

Brady J, Radonovich M, Thoren M, Das G, Salzman NP.

Mol Cell Biol. 1984 Jan;4(1):133-41.

49.

Site-specific base substitution and deletion mutations that enhance or suppress transcription of the SV40 major late RNA.

Brady J, Radonovich M, Vodkin M, Natarajan V, Thoren M, Das G, Janik J, Salzman NP.

Cell. 1982 Dec;31(3 Pt 2):625-33.

PMID:
7159930
50.

Accurate transcription of simian virus 40 chromatin in a HeLa cell extract.

Brady JN, Radonovich M, Salzman NP.

J Virol. 1982 Dec;44(3):772-81.

Supplemental Content

Loading ...
Support Center